Basal cell carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients with primary BCC confirmed by pathological examination, including nodular type, superficial diffuse type, micronodular type, mixed type and other types of BCC; 2. in accordance with the principle of putting the interests of patients first, the number of lesions in BCC or the diameter of a single lesion >=0.5cm is recommended to be included in the control group such as Mohs, and the experimental group is recommended for lesions with large area, multiple lesions and H area such as nose; 3. sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe liver, kidney and heart disease or immune deficiency; 2. Patients with a history of mental illness and epilepsy, etc.; 3. Women during lactation or pregnancy; 4. Patients are known to have skin photosensitivity, porphyria or allergy to porphyrins; 5. People who are known to be allergic to iodine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete remission rate of skin lesions at 3 months after the last treatment; | — |
Countries
China
Contacts
Xiangya Hospital Central South University